Skip to main content
logo
Arch Biopartners Inc. (ACHFF)
OTCMKTS · Delayed Price · Currency is USD
0.5900
+0.0100 (1.72%)
Jul 28, 2026, 12:36 PM EST

Arch Biopartners Cash Flow Statement

Millions CAD. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
-2.78-1.55-3.92-3.33-1.41-1.17
Other Operating Activities
1.69-0.031.593.091.89-1.81
Operating Cash Flow
-1.09-1.58-2.33-0.230.48-2.98
Operating Cash Flow Growth
------

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Long-Term Debt Issued
-0.340.351.5-2.2
Long-Term Debt Repaid
---0.21-1.07-0.79-0.47
Net Debt Issued (Repaid)
-0.30.340.140.43-0.791.73
Issuance of Common Stock
1.821.251.360.130.371.05
Financing Cash Flow
1.521.581.50.56-0.422.78

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Cash Flow
0.43-0-0.830.320.06-0.21

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Levered Free Cash Flow
-0.24-1.19-1.290.680.61-2.54
Unlevered Free Cash Flow
-0.08-1.03-1.050.910.8-2.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash Interest Paid
0.03--00.080.07